Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding

about

Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding

Item

http://www.wikidata.org/entity/Q36947200

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dynamic monitoring of menopaus ...... ckness during uterine bleeding

@en

type

Item

label

Dynamic monitoring of menopaus ...... ckness during uterine bleeding

@en

prefLabel

Dynamic monitoring of menopaus ...... ckness during uterine bleeding

@en

P1476

Dynamic monitoring of menopaus ...... ckness during uterine bleeding

@en

P2093

Fen Li

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

Qiaoling Zhao

http://www.w3.org/2001/XMLSchema#string

Qiu Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis

Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding.

Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach.

Hormone replacement therapy in gynecologic cancer survivors: why not?

Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.

A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.

Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.

Prevalence of polycystic ovaries by transvaginal ultrasound and serum androgens.

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

P304

191-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7555/JBR.30.20150147

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27533929

http://www.w3.org/2001/XMLSchema#string

P932

4885166

http://www.w3.org/2001/XMLSchema#string